Home > Boards > US OTC > Biotechs > Cytodyn Inc. (CYDY)

Explain how that last line is possible. What

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Black-Ops Member Profile
 
Followed By 126
Posts 2,302
Boards Moderated 0
Alias Born 06/21/18
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 1/10/2022 5:13:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/5/2022 5:16:52 PM
CytoDyn's leronlimab in 350 mg weekly dose met endpoints in Phase 2 NASH trial Seeking Alpha - 1/5/2022 9:38:39 AM
IQST - $0.60 Sleeper Stock Set To Explode In Fintech Parade Of Decacorn IPO's InvestorsHub NewsWire - 12/23/2021 11:51:16 AM
CytoDyn receives positive response from FDA for Phase 3 leronlimab study in COVID-19 Seeking Alpha - 12/21/2021 9:28:46 AM
CytoDyn files for expanded access use of leronlimab for HIV patients Seeking Alpha - 12/9/2021 9:13:36 AM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:32:42 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:32:41 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 11/30/2021 6:31:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:30:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:27:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/29/2021 6:20:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 5:22:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/24/2021 4:05:01 PM
CytoDyn reports leronlimab data in NASH trial for first 15 patients Seeking Alpha - 11/24/2021 10:08:44 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/23/2021 5:24:15 PM
SA Breaking News - PURA estimates $1M in 2022 revenue InvestorsHub NewsWire - 11/22/2021 9:38:18 AM
PURA BULLISH RESURGANCE InvestorsHub NewsWire - 11/19/2021 8:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/17/2021 6:02:41 AM
CytoDyn submits the first section of HIV BLA to FDA under rolling review Seeking Alpha - 11/16/2021 7:07:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/9/2021 4:55:20 PM
CytoDyn submits leronlimab Breakthrough Therapy designation application to the FDA Seeking Alpha - 11/8/2021 7:50:43 AM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 11/5/2021 11:30:49 AM
CytoDyn posts preliminary results from mid-stage leronlimab NASH study Seeking Alpha - 11/3/2021 6:11:13 AM
iQSTEL, Inc. - The Calm Before The Surge (OTCQX: IQST) InvestorsHub NewsWire - 10/29/2021 2:31:48 PM
Black-Ops   Thursday, 11/25/21 10:07:12 AM
Re: 3X Charm post# 194657
Post # of 201276 
Explain how that last line is possible. What SEC rule would this be true? Laymen terms are OK.

Are you saying that CYDY is selling REGISTERED common shares in Private Placements???



How does an investor in a CYDY Private Placement sell those shares quickly?

The only way would be IF the shares were registered.

Lets define quickly as a few days to a week.

Explain what I do not believe is possible, UNLESS REGISTERED. Meaning the shares would not be restricted!!!!!

What have I missed in the last 50 years?????



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences